Results

eNauka >  Rezultati >  The Impact of Upadacitinib Versus Methotrexate Or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis
Naziv : The Impact of Upadacitinib Versus Methotrexate Or Adalimumab on Individual and Composite Disease Measures in Patients with Rheumatoid Arthritis
Autori: Van, Vollenhoven Ronald; Ostor, Andrew; Mysler, Eduardo; Damjanov, Nemanja S; Song, In-Ho; Song, Yanna; Suboticki, Jessica; Strand, Vibeke
Godina: 2020
Publikacija: ANNALS OF THE RHEUMATIC DISEASES
ISSN: 0003-4967 Annals of the Rheumatic Diseases Pretraži identifikator
Tip rezultata: Konferencijski rad
Kolacija: vol. 79 br. Suppl 1 str. 647-652
DOI: 10.1136/annrheumdis-2020-eular.1426
WoS-ID: 000555905002103
URI: https://enauka.gov.rs/handle/123456789/811529
Izvor metapodataka: (Preuzeto iz Nasi u WoS)
M-kategorija: 
Mp kategorija će biti prikazana naknadno.

1
OpenCitations
Altmetric
Dimensions
Unpaywall

Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.